Retatrutide is the first triagonist that we're heading to the market with, which were hoping sets a new standard in weight loss and patient benefit. TIDES Europe Nov 3, 2026 TO Nov 5, 2026 | Amsterdam, Netherlands Europe's largest and most comprehensive oligonucleotide and peptide therapeutics event featuring scientific breakthroughs, manufacturing innovations, and regulatory insights
The weight loss medication that looks best on paper may not be the one that delivers the best results
Products for parenteral use should be visually inspected before administration, when the container or the solution makes it possible, in order to possibly detect the presence of particles or of an abnormal color
And here's where things get interesting
Consult your GP or pharmacist before starting ispaghula if you have swallowing difficulties, gastrointestinal obstruction, diabetes, or take multiple medications